IC
WST icon

Inscription Capital’s West Pharmaceutical WST Stock Holding History

Inscription Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$469K Buy
1,871
+347
+23% +$86.3K 0.05% 383
2025
Q4 		$419K Buy
1,524
+5
+0.3% +$1.37K 0.04% 407
2025
Q3 		$398K Buy
+1,519
New +$369K 0.04% 409

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Inscription Capital's WST Position: Q1 2026 in Review

Inscription Capital increased its West Pharmaceutical (WST) stake by 23% in Q1 2026, buying an estimated $86.3K and bringing the position to 1,871 shares worth $469K. The position accounts for 0.05% of the portfolio, ranked #383.

Inscription Capital first reported a position in WST in Q3 2025 and has held it in 3 quarters since. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Inscription Capital held 1,871 shares of West Pharmaceutical worth $469K as of Q1 2026.
  • Inscription Capital bought 347 West Pharmaceutical shares in Q1 2026, an estimated $86.3K.
  • West Pharmaceutical made up 0.05% of Inscription Capital's portfolio in Q1 2026, its #383 holding.
  • Inscription Capital first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.